Ourofino (OFSA3.SA) Stock Price

Ourofino Price

CLOSED
29.83
​
Market closed

Over the last 14 years Ourofino grew revenue by 10.7% annually, reaching 1.22 B BRL. Earnings per share have grown at 14.3% per year over the last 11 years. For Ourofino, the net margin of 18.1% is up versus 12.6% a few years ago. At today's price the dividend yield works out to roughly 10.91%. The payout ratio is around 79% of earnings. The dividend has grown at 25.8% per year over the past 10 years. The consensus 12-month price target for Ourofino is 21.42 BRL, about 28.2% below where the stock trades today. Of 7 analysts, 0 rate the stock a buy — an overall Sell consensus.

Ourofino stock price

Access this data via the Eulerpool API

Ourofino business model & stock analysis

Ouro Fino Saúde Animal Participações SA engages in the development, production, and sale of veterinary drugs, vaccines, and other products for production and companion animals. The firm manufactures veterinary products using scientific technology in the Company's laboratories. The firm's products are divided into six sectors: Wholesale, Birds, Cattle, Equine, Pet and Pigs. The Wholesale area is divided into four lines: Anti-Mastiticos, producing antibiotics killing bacteria and lumps; Antimicrobial, which focuses on the treatment of bacterial infectious diseases; Ectoparasiticides, concentrated on insect repellent products, and Endectocides, which is the treatment and control of internal and external diseases of cattle, sheep and swine parasites. There is also one additional line of products divided for additives, biological, inoculants, diagnostic kit, probiotics, silage and other supplements, among others.

Frequently asked questions about Ourofino

Analysts currently set an average price target of 21.42 BRL for the Ourofino stock (median: 21.42 BRL), implying -28.2 % versus the latest price. The consensus is based on 7 analyst ratings.

7 analysts currently rate the Ourofino stock: 0 recommend buying, 3 holding and 4 selling. For 2026, analysts expect Ourofino to generate revenue of 1.20 B BRL and earnings per share of 2.40 BRL.

Converted at the current exchange rate, the Ourofino share trades at 5.31 EUR (29.83 BRL).

The expected revenue of Ourofino is 1.20 B BRL. This figure is based on current financial data and reflects the company's business performance.

The expected profit of Ourofino is 128.92 M BRL. The net profit reflects the company's profitability after deducting all expenses.

The price-to-earnings ratio (P/E) of Ourofino is currently 12.44. The P/E ratio compares the current share price to the earnings per share and helps investors assess the valuation of the Ourofino stock.

The price-to-sales ratio (P/S) of Ourofino is currently 1.34. The P/S ratio compares the market capitalization to the annual revenue and serves as a valuation metric for the Ourofino stock.

The Eulerpool Quality Score for Ourofino is 5/10.

The ISIN of Ourofino is BROFSAACNOR7. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.

The ticker of Ourofino is OFSA3.SA. The ticker symbol is used to trade Ourofino shares on the stock exchange.

Fair ValueTerminal
27.44 BRL
Over-/UndervaluationTerminal
Fairly valued
Sector
Industry
Pharmaceuticals
Number of shares
Employees
Revenue growth Ø5 years
EBIT growth Ø5 years
Net Income growth Ø5 years
Country
Brazil
Currency
BRL
Initial public offering
Oct 21, 2014
ISIN
BROFSAACNOR7
Cusip
P7S875102
Market capitalization
1.61 B BRLSmall Cap
52-Week Range
PEG
—
P/E ratio
P/Ee 2026
12.48
P/Ee 2027
—
P/S
P/Se
1.34
EV/EBIT
7.59
P/B Ratio
2.02
ROE (Return on Equity)
ROA (Return on Assets)
ROCE (Return on Capital Employed)
ROIC (Return on Invested Capital)
18.01 %
Dividend
Dividend yield
10.91 %
Est. Dividend Yield
1.21 %
Payout Ratio
78.72 %
Dividend growth Ø5Y
-11.85 %
Dividend payments per year
3
Dividend paid since
11 years
Dividend not reduced since
2 years
Dividend increased since
2 years
Dividend withholding tax
10.00 %
Last updated Oct 9, 2026, 11:35 PM

Ourofino Peer Group

Ourofino FIGI

OFSA3:BZ · BBG001BS35B6OFSA3:BS · BBG0077WZXT4OFSA3:BN · BBG0077WZXX9

All fundamentals and in-depth analysis of Ourofino

Our stock analysis for Ourofino stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Ourofino. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.